Miopía y estrías retinianas por topiramato

  1. E. Dorronzoro
  2. E. Santos-Bueso
  3. E. Vico-Ruiz
  4. F. Sáenz-Frances
  5. J. Argaya
  6. J.A. Gegúndez-Fernández
Revista:
Archivos de la Sociedad Española de Oftalmologia

ISSN: 0365-6691

Año de publicación: 2011

Volumen: 86

Número: 1

Páginas: 24-26

Tipo: Artículo

DOI: 10.4321/S0365-66912011000100005 DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Archivos de la Sociedad Española de Oftalmologia

Objetivos de desarrollo sostenible

Resumen

Clinical case: A 23-year-old woman who was seen due to decreasing far visual acuity 24hours after starting treatment with topiramate. In the cycloplegic refraction, RE showed -4.25 and LE -4.50. Retinal striae could be seen in the macula of both eyes. The alterations ceased 48hours after the drug treatment was interrupted. Discussion: Drug induced acute myopia is an infrequent phenomenon, the aetiology of which is still not fully known.

Referencias bibliográficas

  • Fraunfelder, FW, Fraunfelder, FT, Keates, EU. (2004). Topiramate-associated acute, bilateral, secondary angle-closure glaucoma. Ophthalmology. 111. 109
  • Shear, MJ, Rowan, AJ, Weiner, JA, Haug, SJ, Mindel, JS. (1990). Drug induced myopia: a transient side effect of topiramate. Epilepsia. 31. 643
  • Gubbay, SS. (1998). The occurrence of drug induced myopia as a transient side effect of topiramate. Epilepsia. 39. 451
  • Rhee, DJ, Goldberg, MJ, Parrish, RK. (2001). Bilateral angle-closure glaucoma and ciliary body swelling from topiramate. Arch Ophthalmol.. 119. 1721
  • Sen, H, O'Halloran, H, Lee, W. (2001). Topiramate-induced acute myopia and retinal striae. Arch Ophthalmol.. 119. 775
  • Guier, CP. (2007). Elevated intraocular pressure and myopic shift linked to topiramate use. Optom Vis Sci.. 84. 1070
  • Asensio-Sánchez, VM, Torreblanca-Agüera, B, Martínez Calvo, S, Calvo, MJ, Rodríguez, R. (2006). Severe ocular side effects with Topamax. Arch Soc Esp Oftalmol.. 81. 345
Fuente de los datos: Dialnet